• Dr Jake Sloane & David Segal - 'What's trending in Aesthetics? (Chapter 11 - Part 1)' #297

  • 2025/04/11
  • 再生時間: 1 時間 10 分
  • ポッドキャスト

Dr Jake Sloane & David Segal - 'What's trending in Aesthetics? (Chapter 11 - Part 1)' #297

  • サマリー

  • Episode 297 showcases our hosts Dr Jake Sloane & David Segal

    With political issues and the economic climate changing almost every day, we're publishing this episode out of sync with our usual Friday podcast. What we recorded just 4 weeks ago dated quite a lot and so we decided to record a second part to this episode to also address the tariff situation, the stock market volatility and what these mean for aesthetic clinics.

    • Part 1 (this episode) is free and available to listen to on your favourite podcast app
    • Part 2 (also out now!) is exclusive for subscribers to our Patreon (CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH!)

    In Chapter 11 (Part 1) of 'What's Trending in Aesthetics,' we reflect on the introduction of another new toxin into the Australian market. We first tackle how clinics will need to understand both the clinical but also financial implications of this. We discuss the challenges of introducing new products into your business, particularly focusing on toxins and fillers.

    We highlight the vital importance of:

    • Critical analysis when it comes to understanding clinical studies
    • Transparent communication with patients if you change their usual product to something else
    • Pricing strategies
    • Understanding the nuances of different toxin and filler products.

    We also touch on the importance of clinical photography, scheduling routine reviews of patients, the potential pitfalls of packaging treatments and the perception of 'top-ups.'

    We conclude with practical advice on balancing margins and cash flow when making business decisions when it come to purchasing and pricing products.

    00:00 Introduction and Personal Updates

    00:25 Workshop Insights and Business Literacy

    02:19 Financial Health and Business Strategies

    07:26 Engagement and Community Building

    10:00 Pricing and Introducing New Products

    15:39 Navigating Industry Challenges

    34:16 Critical Analysis of Medical Papers

    34:49 Understanding Non-Inferiority Studies

    35:42 Communicating with Patients About New Products

    36:39 Conducting Internal Studies and Trials

    37:37 Evaluating Toxin Performance and Patient Feedback

    39:18 Challenges with New Toxins

    45:42 Considerations for Fillers

    50:14 Pricing and Packaging Strategies

    56:45 Avoiding Free Top-Ups and Setting Expectations

    01:01:09 Valuing Skills Over Product Quantity

    01:05:47 Final Thoughts and Practical Advice

    CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH

    CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS

    CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US

    CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST

    CONTACT US

    続きを読む 一部表示

あらすじ・解説

Episode 297 showcases our hosts Dr Jake Sloane & David Segal

With political issues and the economic climate changing almost every day, we're publishing this episode out of sync with our usual Friday podcast. What we recorded just 4 weeks ago dated quite a lot and so we decided to record a second part to this episode to also address the tariff situation, the stock market volatility and what these mean for aesthetic clinics.

  • Part 1 (this episode) is free and available to listen to on your favourite podcast app
  • Part 2 (also out now!) is exclusive for subscribers to our Patreon (CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH!)

In Chapter 11 (Part 1) of 'What's Trending in Aesthetics,' we reflect on the introduction of another new toxin into the Australian market. We first tackle how clinics will need to understand both the clinical but also financial implications of this. We discuss the challenges of introducing new products into your business, particularly focusing on toxins and fillers.

We highlight the vital importance of:

  • Critical analysis when it comes to understanding clinical studies
  • Transparent communication with patients if you change their usual product to something else
  • Pricing strategies
  • Understanding the nuances of different toxin and filler products.

We also touch on the importance of clinical photography, scheduling routine reviews of patients, the potential pitfalls of packaging treatments and the perception of 'top-ups.'

We conclude with practical advice on balancing margins and cash flow when making business decisions when it come to purchasing and pricing products.

00:00 Introduction and Personal Updates

00:25 Workshop Insights and Business Literacy

02:19 Financial Health and Business Strategies

07:26 Engagement and Community Building

10:00 Pricing and Introducing New Products

15:39 Navigating Industry Challenges

34:16 Critical Analysis of Medical Papers

34:49 Understanding Non-Inferiority Studies

35:42 Communicating with Patients About New Products

36:39 Conducting Internal Studies and Trials

37:37 Evaluating Toxin Performance and Patient Feedback

39:18 Challenges with New Toxins

45:42 Considerations for Fillers

50:14 Pricing and Packaging Strategies

56:45 Avoiding Free Top-Ups and Setting Expectations

01:01:09 Valuing Skills Over Product Quantity

01:05:47 Final Thoughts and Practical Advice

CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH

CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS

CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US

CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST

CONTACT US

Dr Jake Sloane & David Segal - 'What's trending in Aesthetics? (Chapter 11 - Part 1)' #297に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。